Growth Metrics

NeuroPace (NPCE) Shares Outstanding (Weighted Average) (2020 - 2025)

NeuroPace has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $32.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Weighted Average) at $32.7 million for Q4 2025, up 12.35% from a year ago — trailing twelve months through Dec 2025 was $32.7 million (up 12.35% YoY), and the annual figure for FY2025 was $32.7 million, up 12.35%.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $32.7 million at NeuroPace, up from $32.5 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for NPCE hit a ceiling of $32.9 million in Q2 2025 and a floor of $269178.0 in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $25.4 million (2023), compared with a mean of $25.1 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): surged 11808.86% in 2021 and later rose 1.72% in 2022.
  • NeuroPace's Shares Outstanding (Weighted Average) stood at $16.6 million in 2021, then skyrocketed by 48.08% to $24.6 million in 2022, then increased by 5.11% to $25.9 million in 2023, then rose by 12.67% to $29.1 million in 2024, then rose by 12.35% to $32.7 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $32.7 million (Q4 2025), $32.5 million (Q3 2025), and $32.9 million (Q2 2025) per Business Quant data.